Clinical ResearchEstablishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas☆
Under a Creative Commons license
open archive
Keywords
Non-Hodgkin's lymphoma
Allogeneic
Reduced intensity
Chimerism
Cited by (0)
- ☆
Correspondence and reprint requests: Michael R. Bishop, MD, Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 12N226, Bethesda, MD 20892 (e-mail: [email protected]).
Copyright © 2003 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.